Hematology & Oncology Doctors in Beaver, PA Accepting Medicare

6 Hematology & Oncology doctors found. Showing 1 - 6

Gerald R Medwick, D.O. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-7616    Fax: 724-773-4673

Stewart L Lancaster, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 605 Sharon Rd, Beaver, PA 15009 Phone: 724-774-0778    Fax: 724-774-1109

Grace Tarabay, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 605 Sharon Rd, Beaver, PA 15009 Phone: 724-774-0778

Yehuda Lebowicz, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1030 Beaner Hollow Rd, Beaver, PA 15009 Phone: 917-930-1982

William Ferri, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1030 Beaner Hollow Rd, Beaver, PA 15009 Phone: 724-774-0778

Moon Fenton, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1030 Beaner Hollow Rd, Beaver, PA 15009 Phone: 724-774-0778

News Archive

Massachusetts looks to other states for website fixes

Among possible ways to resolve the continuing issues, state officials are contemplating the possibility of buying or leasing technology from states where the online insurance marketplace is working. They also are considering scrapping the current website and starting over. News outlets also track developments in Maryland, California and Illinois.

NewLink Genetics receives FDA SPA approval for HyperAcute immunotherapy Phase 3 pancreatic cancer trial

NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial to be used in support of a Biologic License Application (BLA).

Male fetuses impair the maternal and placental immune response to SARS-CoV-2 infection in pregnancy, finds study

The ongoing COVID-19 pandemic, caused by SARS-CoV-2, is now established to be more likely to lead to symptomatic and serious illness in males relative to females. This may extend as far back as pregnancy, suggests a recent study.

Reported failure of vitamin E to prevent heart attacks may be due to underdosing

The findings, published early online in Free Radical Biology and Medicine, suggest that these earlier studies all had a fundamental flaw the doses used werent high enough to have a significant antioxidant effect.

New research shows statins could reduce common diabetes complications

The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology.

Read more Medical News

› Verified 1 days ago